Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
about
Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challengesTargeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancerTriple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery.Enhanced singlet oxygen production by photodynamic therapy and a novel method for its intracellular measurementNear-infrared light activated delivery platform for cancer therapyActivated T cells exhibit increased uptake of silicon phthalocyanine Pc 4 and increased susceptibility to Pc 4-photodynamic therapy-mediated cell deathA cell-targeted photodynamic nanomedicine strategy for head and neck cancers.Developments in PDT Sensitizers for Increased Selectivity and Singlet Oxygen Production.Glutathione-Activatable and O2 /Mn2+ -Evolving Nanocomposite for Highly Efficient and Selective Photodynamic and Gene-Silencing Dual Therapy
P2860
Q26827820-DC0FF7E2-ED76-4457-AE83-AC29EF88F47BQ34139484-FCAB62F7-FAD8-41BF-B7CD-92541E5CCF10Q34146404-47CA0ACF-AAF6-4556-96DA-56FD1277FD6FQ34711271-FC852A72-7902-49E3-8124-C9C8CF26E883Q36373450-EB7923AB-4AE8-4923-941A-77EF2780BB1EQ37055477-05D5B27A-DA07-4A3D-969D-7D7E03236023Q37190425-3D292006-32E8-4E67-892E-E42D7FF27077Q41961435-855DF01E-8EAA-4D1C-9BEE-5751622DABFBQ58376430-6DE466AC-9BDB-4609-9F6F-475270CE5A30
P2860
Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Optimization of a nanomedicine ...... f EGFR-overexpressing cancers.
@ast
Optimization of a nanomedicine ...... f EGFR-overexpressing cancers.
@en
type
label
Optimization of a nanomedicine ...... f EGFR-overexpressing cancers.
@ast
Optimization of a nanomedicine ...... f EGFR-overexpressing cancers.
@en
prefLabel
Optimization of a nanomedicine ...... f EGFR-overexpressing cancers.
@ast
Optimization of a nanomedicine ...... f EGFR-overexpressing cancers.
@en
P2093
P2860
P356
P1476
Optimization of a nanomedicine ...... f EGFR-overexpressing cancers.
@en
P2093
Alyssa M Master
Anirban Sen Gupta
Megan Livingston
Nancy L Oleinick
P2860
P304
P356
10.1021/MP300256E
P407
P577
2012-07-19T00:00:00Z